377 reports of this reaction
2.2% of all GLYCERIN reports
#8 most reported adverse reaction
HEADACHE is the #8 most commonly reported adverse reaction for GLYCERIN, manufactured by Geri-Care Pharmaceuticals, Corp. There are 377 FDA adverse event reports linking GLYCERIN to HEADACHE. This represents approximately 2.2% of all 16,949 adverse event reports for this drug.
Patients taking GLYCERIN who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is a less commonly reported adverse event for GLYCERIN, but still significant enough to appear in the safety profile.
In addition to headache, the following adverse reactions have been reported for GLYCERIN:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 377 FDA reports for GLYCERIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 2.2% of all adverse event reports for GLYCERIN, making it a notable side effect.
If you experience headache while taking GLYCERIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.